| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $58.97 ▼ -0.71% | Yesterday | $59.57 ▲ +0.30% | Tomorrow's Bristol-Myers Squibb Company Common Stock (BMY) setup is anchored to $59.39 and targets $58.97 (-0.71%). The near-term read is downside; watch $61.17 / $57.61 because daily realized volatility is about 3.65%. |
Tomorrow's Bristol-Myers Squibb Company Common Stock (BMY) setup is anchored to $59.39 and targets $58.97 (-0.71%). The near-term read is downside; watch $61.17 / $57.61 because daily realized volatility is about 3.65%. | ||||
| Week | $58.08 ▼ -2.20% | Last Week | $59.94 ▲ +0.92% | The 7-day Bristol-Myers Squibb Company Common Stock model moves from $59.94 to $58.08 (-2.20%). It gives downside momentum context for this stock, so breaks around $61.17 / $57.61 matter more than a single tick. |
The 7-day Bristol-Myers Squibb Company Common Stock model moves from $59.94 to $58.08 (-2.20%). It gives downside momentum context for this stock, so breaks around $61.17 / $57.61 matter more than a single tick. | ||||
| Month | $56.61 ▼ -4.69% | Last Month | $60.56 ▲ +1.97% | The 1-month Bristol-Myers Squibb Company Common Stock target is $56.61 (-4.69%), compared with the live reference near $59.39. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Bristol-Myers Squibb Company Common Stock target is $56.61 (-4.69%), compared with the live reference near $59.39. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $54.39 ▼ -8.41% | Last Year | $61.49 ▲ +3.53% | The 1-year Bristol-Myers Squibb Company Common Stock scenario points to $54.39 (-8.41%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Bristol-Myers Squibb Company Common Stock scenario points to $54.39 (-8.41%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $49.21 ▼ -17.14% | 5 Years Ago | $63.67 ▲ +7.20% | The 5-year Bristol-Myers Squibb Company Common Stock view is $49.21 (-17.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Bristol-Myers Squibb Company Common Stock view is $49.21 (-17.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| Price | $59.39 | Mid |
| Daily Change | +0.44% | Above |
| Volatility Cap | 20.0% | Mid |
| Confidence | 58% | Below |
| Data Source | nasdaq-screener | Mid |
| Current | $59.39 | Daily Change | +0.44% |
| Market Cap | $121.26B | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.